Download presentation
Presentation is loading. Please wait.
Published bySavanna Claycomb Modified over 9 years ago
1
Using Gene Knockout and Transgenic Approaches to Evaluate in vivo Functions of CNS Regeneration Inhibitors: How Important is Nogo ? David Mann Tammy Hibler Isaac Holmes Arun George Paul
2
Road Map Background Background Hypotheses Hypotheses Specific Aims Specific Aims Expected Results Expected Results Conclusion Conclusion Future Research Future Research
3
The Big Picture Alzheimer’s Disease Alzheimer’s Disease Parkinson’s Disease Parkinson’s Disease Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Huntington’s Disease Huntington’s Disease http://content.karger.com/ProdukteDB/produkte.asp?Aktion=JournalHome&ProduktNr=229093 Background
4
Spinal Cord Injury Cervical (C1-8) Thoracic (T1-12) Lumbar (L1-5) Sacral (S1-5) Coccygeal (C1) SCI on CST Purves, Dale et.al. Neuroscience. Sinauer Associates, Inc.2000. p14. Background
5
What are the myelin-derived inhibitors? MAG OMgp NgR Receptor 66 Amino Acid Domain Nogo-B Nogo-A Nogo-C CNS Neuron Fournier et. al. (2001) Identification of a receptor mediating Nogo-66 inhibition of axonal regeneration. Nature 409: 341-346. Background
6
Nogo Controversy BackgroundLabKnockoutMouse Extent of Regeneration Schwab Nogo-A - Modest Strittmatter Nogo-A/B -/- (6-11 weeks) Significant Strittmatter Nogo-A/B -/- (>11 weeks) None Hypothesis 2 Hypothesis 1
7
Our Hypotheses Hypothesis 1: Modest axonal regeneration in Schwab’s Nogo-A - mice was due to the presence of Nogo-B Hypothesis 1: Modest axonal regeneration in Schwab’s Nogo-A - mice was due to the presence of Nogo-B Hypothesis 2: Absence of axonal regeneration in older mice was due to increased age-dependant inhibition by OMgp Hypothesis 2: Absence of axonal regeneration in older mice was due to increased age-dependant inhibition by OMgp
8
Specific Aims Nogo-B Schwab Nogo-A/B -/- Mice WT OMgp (Young vs. Adult) Nogo-A/Nogo-B -/- -OMgp - OMgp ++ Hypothesis 2 Hypothesis 1 Aim 1 Aim 2 Aim 3 Aim 4
9
Aim 1: Aim 1: To study inhibitory effects of Nogo-B on axonal regeneration in Nogo-A - Mice Rationale: The presence of Nogo-B should account for the modest axonal regeneration in Schwab’s Nogo- A- mouse What we propose: Increased Axonal Regeneration Nogo-B Schwab’s Nogo-A - mouse Aim
10
Creation of the Nogo-A/B -/- Knockout Mouse using a Gene trapping vector A/B A A A/B/C 1 2 3 4-9 Nogo Gene Exon 1 Nogo-B IRES-ß-geoPKG-NEO Gene Construct Schwab Aim
11
Has Nogo-B really been knocked out? In vitro test 1: Northern Blot WT Nogo-B mRNA Nogo-A - -actin Negative Control Nogo-A/B -/- Expected Result
12
Has Nogo-B really been knocked out? In vitro test 2: Western Blot Nogo-B protein WTNogo-A - MAG protein Negative Control Nogo- A/B -/- Expected Result
13
Is the absence of Nogo-B affecting the general brain structure? In vivo test: Histological Analysis Nogo- A/B -/- Cerebral Cortex Hematoxylin & Eosin Staining Wild Type X-gal Staining Cerebellum Corpus Callosum Expected Result Nogo- A/B -/-
14
How does the absence of Nogo-B affect axonal growth? In vitro Neurite Outgrowth Assay Growth Cone Assay Control Nogo-A - Nogo-A/B -/- Expected Result
15
Where & what are we looking for? In vivo Aim Dorsal Ventral Ipsi- Lateral Ventral Ipsi- Lateral ? ? ? ? T6 Dorsal Contra- Lateral Dorsal Contra- Lateral Rostral Caudal T4 L2
16
How does the absence of Nogo-B affect axonal regeneration after SCI? In vivo Dorsal Ventral Dorsal Ventral Dorsal Ventral Dorsal Ventral Dorsal Ventral Dorsal Ventral Coronal Sections at T4 (Rostral) Coronal Sections at L2 (Caudal) Coronal Studies: Control Nogo-A - Nogo-A/B -/- Expected Result CST
17
How does the absence of Nogo-B affect axonal regeneration after SCI? In vivo Wild Type Nogo-A - Nogo- A/B -/- Sagittal Studies: Expected Result SCI CST
18
How does the absence of Nogo-B affect functional recovery after SCI? 20 15 10 5 0 5 15 20 Nogo-A - Nogo-A/B -/- Behavioral Study: Expected Result Days Post SCI BBB Score
19
What we expect… More Axonal Regeneration Nogo-B Schwab Nogo-A - mice Expected Result
20
Aim 2: To study the expression of OMgp in wild-type mice: young (6-11 weeks) vs. adult (>11 weeks) What we propose (6-11 weeks) Younger Mice (6-11 weeks) (>11 weeks) Adult Mice (>11 weeks) Low OMgp Expression Increased OMgp Expression Rationale: OMgp expression should increase with age to account for age-dependant inhibition seen in Strittmatter’s Nogo-A/B -/- mice Aim
21
Does OMgp expression increase in adult mice? In vitro test 1: Northern Blot OMgp mRNA ß-actin mRNA Week 6 Week 11 Week 14 Expected Result
22
Does OMgp expression increase in adult mice? In vitro test 2: Western Blot Week 6 Week 11 Week 14 OMgp Protein MBP Expected Result
23
Does OMgp expression increase in adult mice? In vitro test 3: Immunohistochemistry Cerebellum Cerebral Cortex Lung Spinal Cord 6 weeks11 weeks14 weeks Expected Result
24
Does OMgp expression increase in adult mice? In vitro test 4: In Situ Hybridization Cerebellum 6 weeks Cerebral Cortex Lung 11 weeks14 weeks Spinal Cord Expected Result
25
What we expect… (6-11 weeks) Young Mice (6-11 weeks) (>11 weeks) Adult Mice (>11 weeks) Low OMgp ExpressionIncreased OMgp Expression Expected Result
26
Aim 3: Part 1: To study the inhibition by OMgp in wild-type mice: young (6-11 weeks) vs. adult (>11 weeks) What we propose Younger OMgp -/- Mice (6-11 weeks) Adult OMgp -/- Mice (>11 weeks) No Axonal Regeneration Axonal Regeneration Rationale: If OMgp is an inhibitor in adult mice, then absence of OMgp in adult mice will lead to axonal regeneration in adult OMgp -/- Mice Aim
27
Creation of the OMgp -/- Knockout Mouse Wild Type OMgp -/- Aim
28
Has OMgp really been knocked out? In vitro Northern Blot Northern Blot Western Blot Western Blot Histological Analysis Histological Analysis Expected Result Is the absence of OMgp affecting motor functions? Rotarod Test Rotarod Test
29
How does the absence of OMgp affect axonal growth? In vitro Neurite Out- growth Assay Growth Cone Assay OMgp -/- OMgp -/- Control OMgp -/- OMgp -/- (11-14 weeks) (6-11 weeks) Expected Result
30
Where & what are we looking for? In vivo Aim Dorsal Ventral Ipsi- Lateral Ventral Ipsi- Lateral ? ? ? ? T6 Dorsal Contra- Lateral Dorsal Contra- Lateral Rostral Caudal T4 L2
31
How does the absence of OMgp affect axonal regeneration? In vivo Dorsal Ventral Dorsal Ventral Dorsal Ventral Dorsal Ventral Dorsal Ventral Dorsal Ventral Coronal Sections at T4 (Rostral) Coronal Sections at L2 (Caudal) Coronal Studies: Wild Type OMgp -/- OMgp -/- (Adult) OMgp -/- OMgp -/- (Young) Expected Result CST
32
How does OMgp inhibition affect axonal regeneration? In vivo Wild Type OMgp -/- OMgp -/- (Adult) OMgp -/- OMgp -/- (Young) Sagittal Studies: Expected Result SCI CST
33
What we expect… Young OMgp -/- Mice (6-11 weeks) Adult OMgp -/- Mice (>11 weeks) No Axonal Regeneration Axonal Regeneration Expected Result
34
Part 2: To study the inhibition of OMgp in Nogo-A/B -/- mice: young (6-11 weeks) vs adult (>11 weeks) Aim 3: Young Nogo-A/B -/- -OMgp - Mice (6-11 weeks) Adult Nogo-A/B -/- -OMgp - Mice (>11 weeks) What we propose Excessive Axonal Regeneration Rationale: If OMgp is an inhibitor in older mice, then the absence of OMgp in young and adult Nogo-A/B -/- mice will have axonal regeneration after SCI Aim
35
Creation of the Nogo-A/B/OMgp -/-/- Knockout Mouse Wild Type Nogo-A/B -/- - OMgp - Aim
36
Has OMgp really been knocked out? In vitro Northern Blot Northern Blot Western Blot Western Blot Histological Analysis Histological Analysis Expected Result Is the absence of OMgp affecting motor functions? Rotarod Test Rotarod Test
37
How does the absence of Nogo-B affect axonal growth in Nogo-A/B -/- mice ? In vitro Nogo-A/B -/- Nogo-A/B -/- OMgp - OMgp - Control Nogo-A/B -/- Nogo-A/B -/- OMgp - (Adult) OMgp - (Younger) Neurite Out- growth Assay Growth Cone Assay Expected Result
38
Where & what are we looking for? In vivo Aim Dorsal Ventral Ipsi- Lateral Ventral Ipsi- Lateral ? ? ? ? T6 Dorsal Contra- Lateral Dorsal Contra- Lateral Rostral Caudal T4 L2
39
How does the absence of Nogo-B affect axonal regeneration in Nogo-A/B -/- mice ? In vivo Dorsal Ventral Dorsal Ventral Dorsal Ventral Dorsal Ventral Dorsal Ventral Dorsal Ventral Coronal Sections at T4 (Rostral) Coronal Sections at L2 (Caudal) Coronal Studies: Nogo-A/B -/- -OMgp - Wild Type YoungAdult Expected Result CST
40
How does the absence of Nogo-B affect axonal regeneration in Nogo-A/B -/- mice ? In vivo Wild Type Nogo-A/B -/- -OMgp - (Adult) Nogo-A/B -/- -OMgp - (Young) Sagittal Studies: Expected Result SCI CST
41
What we expect… Young Nogo-A/B -/- -OMgp - Mice (6-11 weeks) Adult Nogo-A/B -/- -OMgp - Mice (>11 weeks) Excessive Axonal Regeneration Expected Result
42
Aim 4: To study the effects of the overexpression of OMgp in axonal regeneration after SCI in Nogo-A/B -/- mice Rationale: Since older mice highly express OMgp and do not display axonal regeneration, then young Nogo-A/B -/- mice will not display axonal regeneration when overexpressing OMgp. Aim Young Nogo-A/B -/- No Axonal Regeneration Overexpress OMgp What we propose:
43
Creation of Transgenic Nogo-A/B -/- with overexpression of OMgp MBP Promoter OMgp gene P-MBP OMgp gene OMgp ++ -Nogo-A/B -/- Aim
44
Has OMgp really been overexpressed in the Transgenic Nogo-A/B -/- mice? Western Blot OMgp MAG MBP Expected Result WT OMgp + -Nogo-A/B -/- OMgp ++ -Nogo-A/B -/-
45
How does OMgp overexpression affects axonal growth in Nogo-A/B -/- mice ? In vitro tests Control OMgp + -Nogo-A/B -/- OMgp ++ -Nogo-A/B -/- Neurite Outgrowth Growth Cone Collapse Expected Result
46
How does OMgp overexpression affects axonal regeneration in Nogo-A/B -/- mice ? In vivo Wild Type OMgp + - Nogo-A/B -/- OMgp ++ -Nogo-A/B -/- Dorsal Ventral Dorsal Ventral Dorsal Ventral Dorsal Ventral Dorsal Ventral Dorsal Ventral Coronal Sections at T4 (Rostral) Coronal Sections at L2 (Caudal) Coronal Studies: Expected Result
47
How does OMgp overexpression affects axonal regeneration in Nogo-A/B -/- mice ? In vivo Wild Type OMgp + - Nogo- A/B -/- OMgp ++ - Nogo- A/B -/- Sagittal Studies: Expected Result SCI CST
48
How does OMgp overexpression affect axonal regeneration in Nogo-A/B -/- mice ? In vivo 20 15 OMgp + -Nogo-A/B -/- OMgp ++ -Nogo-A/B -/- 10 5 0 0 5 15 20 Days Post SCI BBB Score Behavioral Study Expected Result
49
What we expect… Nogo-A/B -/- No Axonal Regeneration Overexpresses OMgp Expected Result
50
Conclusion Nogo-B Aim 1 Aim 2 Aim 3 Aim 4 Schwab Nogo-A - Mice WT OMgp Nogo-A/Nogo-B -/- -OMgp - OMgp ++ - Nogo-A/B -/- Nogo-B is a secondary inhibitor OMgp is an inhibitor in adult mice
51
Future Research Possible drugs that can inhibit Nogo, OMgp and MAG Possible drugs that can inhibit Nogo, OMgp and MAG Directed pathways for axonal regeneration Directed pathways for axonal regeneration
52
Acknowledgements Dr. Shubhik DebBurman Dr. Shubhik DebBurman Nijee Sharma Nijee Sharma D’Anne Duncan D’Anne Duncan
Similar presentations
© 2025 SlidePlayer.com. Inc.
All rights reserved.